Skip to main content
Log in

Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note

  • Images in Metabolic Medicine
  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  • El-Hattab AW, Adesina AM, Jones J, Scaglia F (2015) MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 116:4–12

    Article  CAS  PubMed  Google Scholar 

  • Finsterer J (2009) Management of mitochondrial stroke-like episodes. Eur J Neurol 16:1178–1184

    Article  CAS  PubMed  Google Scholar 

  • Ficat RP (1985) Idiopathic bone necrosis of the femoral head: early diagnosis and treatment. J Bone Joint Surg Br 67:3–9

    Article  CAS  PubMed  Google Scholar 

  • Fryer RH, Bain J, De Vivo D (2016) Mitochondrial Encephalomyopathy lactic acidosis and stroke-like episodes: a case report and critical reappraisal of treatment options. Pediatr Neurol 56:59–61

    Article  PubMed  Google Scholar 

  • Jing D, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C et al (2009) Dynamic regulation of mitochondrial function by glucocorticoids. PNAS 106(9):3543–3548

    Article  Google Scholar 

  • Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C et al (2017) Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. https://doi.org/10.1038/gim.2017.107

  • Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med 17(9):689–701

    Article  CAS  PubMed  Google Scholar 

  • Rossi FH, Okun M, Yachnis A, Quisling R, Triggs WJ (2002) Corticosteroid treatment of mitochondrial encephalomyopathies. Neurologist 8:313–315

    Article  PubMed  Google Scholar 

  • Walcott BP, Edlow BL, Xia Z, Kahle KT, Nahed BV, Schmahmann JD (2012) Steroid responsive A3243G mutation MELAS: clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss. Neurologist 18(3):159–170

    Article  PubMed  Google Scholar 

  • Weinstein RS (2012) Glucocorticoid-induced osteonecrosis. Endocrine 41(2):183–190

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-Mock Lee.

Ethics declarations

Conflict of interest

None.

Ethical approval

All procedures performed in studies involving human participant were in accordance with the ethical standards of the institutional and national research committee.

Informed consent

Informed consent was obtained from the patient included in the study.

Additional information

Communicated by: Eva Morava

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, H.S., Lee, J.H., Lee, S.H. et al. Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note. J Inherit Metab Dis 41, 277–278 (2018). https://doi.org/10.1007/s10545-017-0110-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-017-0110-y

Navigation